On Monday, Evolus Inc (NASDAQ: EOLS) opened lower -3.48% from the last session, before settling in for the closing price of $6.9. Price fluctuations for EOLS have ranged from $5.71 to $17.12 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 23.91% over the past five years. Company’s average yearly earnings per share was noted -97.96% at the time writing. With a float of $49.65 million, this company’s outstanding shares have now reached $64.77 million.
Evolus Inc (EOLS) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Evolus Inc is 23.41%, while institutional ownership is 79.98%. The most recent insider transaction that took place on Dec 22 ’25, was worth 75,361. In this transaction an insider of this company sold 10,539 shares at a rate of $7.15, taking the stock ownership to the 354,388 shares. Before that another transaction happened on Dec 22 ’25, when Company’s insider sold 2,261 for $7.15, making the entire transaction worth $16,168. This insider now owns 356,821 shares in total.
Evolus Inc (EOLS) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.01 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 0.02) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -97.96% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Check out the current performance indicators for Evolus Inc (EOLS). In the past quarter, the stock posted a quick ratio of 1.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.16 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Evolus Inc (NASDAQ: EOLS) saw its 5-day average volume 0.71 million, a negative change from its year-to-date volume of 1.13 million. As of the previous 9 days, the stock’s Stochastic %D was 16.32%.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 42.41%, which indicates a significant increase from 3.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was lower than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.90, while its 200-day Moving Average is $8.54. Nevertheless, the first resistance level for the watch stands at $6.85 in the near term. At $7.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.14. If the price goes on to break the first support level at $6.55, it is likely to go to the next support level at $6.45. Assuming the price breaks the second support level, the third support level stands at $6.26.
Evolus Inc (NASDAQ: EOLS) Key Stats
There are currently 64,820K shares outstanding in the company with a market cap of 431.70 million. Presently, the company’s annual sales total 266,270 K according to its annual income of -50,420 K. Last quarter, the company’s sales amounted to 68,970 K and its income totaled -15,740 K.
